nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Dyspnoea—Gemcitabine—breast cancer	0.000816	0.00096	CcSEcCtD
Betahistine—Nausea—Vinblastine—breast cancer	0.000815	0.000958	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—breast cancer	0.000814	0.000958	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—breast cancer	0.000814	0.000958	CcSEcCtD
Betahistine—Somnolence—Gemcitabine—breast cancer	0.000814	0.000957	CcSEcCtD
Betahistine—Convulsion—Paclitaxel—breast cancer	0.000814	0.000957	CcSEcCtD
Betahistine—Gastrointestinal disorder—Irinotecan—breast cancer	0.000811	0.000955	CcSEcCtD
Betahistine—Fatigue—Mitoxantrone—breast cancer	0.00081	0.000953	CcSEcCtD
Betahistine—Fatigue—Irinotecan—breast cancer	0.00081	0.000953	CcSEcCtD
Betahistine—Vomiting—Goserelin—breast cancer	0.000809	0.000952	CcSEcCtD
Betahistine—Pruritus—Vinorelbine—breast cancer	0.000806	0.000949	CcSEcCtD
Betahistine—Dyspnoea—Fluorouracil—breast cancer	0.000802	0.000944	CcSEcCtD
Betahistine—Rash—Goserelin—breast cancer	0.000802	0.000944	CcSEcCtD
Betahistine—Hypersensitivity—Thiotepa—breast cancer	0.000802	0.000943	CcSEcCtD
Betahistine—Dermatitis—Goserelin—breast cancer	0.000801	0.000943	CcSEcCtD
Betahistine—Somnolence—Fluorouracil—breast cancer	0.0008	0.000941	CcSEcCtD
Betahistine—Immune system disorder—Capecitabine—breast cancer	0.0008	0.000941	CcSEcCtD
Betahistine—Headache—Goserelin—breast cancer	0.000797	0.000938	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000794	0.000934	CcSEcCtD
Betahistine—Dyspepsia—Fluorouracil—breast cancer	0.000792	0.000932	CcSEcCtD
Betahistine—Nausea—Tamoxifen—breast cancer	0.000791	0.000931	CcSEcCtD
Betahistine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.00079	0.00093	CcSEcCtD
Betahistine—Discomfort—Paclitaxel—breast cancer	0.00079	0.000929	CcSEcCtD
Betahistine—Fatigue—Gemcitabine—breast cancer	0.000789	0.000929	CcSEcCtD
Betahistine—Asthenia—Thiotepa—breast cancer	0.000781	0.000919	CcSEcCtD
Betahistine—Diarrhoea—Vinorelbine—breast cancer	0.00078	0.000917	CcSEcCtD
Betahistine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000777	0.000914	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—breast cancer	0.000776	0.000913	CcSEcCtD
Betahistine—Nausea—Melphalan—breast cancer	0.000775	0.000912	CcSEcCtD
Betahistine—Feeling abnormal—Irinotecan—breast cancer	0.000774	0.000911	CcSEcCtD
Betahistine—Feeling abnormal—Mitoxantrone—breast cancer	0.000774	0.000911	CcSEcCtD
Betahistine—Confusional state—Paclitaxel—breast cancer	0.000773	0.000909	CcSEcCtD
Betahistine—Asthma—Epirubicin—breast cancer	0.000771	0.000907	CcSEcCtD
Betahistine—Pruritus—Thiotepa—breast cancer	0.00077	0.000906	CcSEcCtD
Betahistine—Anaphylactic shock—Paclitaxel—breast cancer	0.000766	0.000902	CcSEcCtD
Betahistine—Flatulence—Capecitabine—breast cancer	0.000759	0.000893	CcSEcCtD
Betahistine—Nausea—Goserelin—breast cancer	0.000756	0.000889	CcSEcCtD
Betahistine—Feeling abnormal—Gemcitabine—breast cancer	0.000754	0.000888	CcSEcCtD
Betahistine—Dizziness—Vinorelbine—breast cancer	0.000754	0.000887	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—breast cancer	0.000753	0.000886	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—breast cancer	0.000753	0.000886	CcSEcCtD
Betahistine—Nervous system disorder—Paclitaxel—breast cancer	0.000752	0.000884	CcSEcCtD
Betahistine—Tachycardia—Paclitaxel—breast cancer	0.000748	0.00088	CcSEcCtD
Betahistine—Urticaria—Mitoxantrone—breast cancer	0.000747	0.000878	CcSEcCtD
Betahistine—Diarrhoea—Thiotepa—breast cancer	0.000745	0.000876	CcSEcCtD
Betahistine—Skin disorder—Paclitaxel—breast cancer	0.000745	0.000876	CcSEcCtD
Betahistine—Feeling abnormal—Fluorouracil—breast cancer	0.000742	0.000873	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000728	0.000856	CcSEcCtD
Betahistine—Vomiting—Vinorelbine—breast cancer	0.000725	0.000852	CcSEcCtD
Betahistine—Dizziness—Thiotepa—breast cancer	0.00072	0.000847	CcSEcCtD
Betahistine—Rash—Vinorelbine—breast cancer	0.000719	0.000845	CcSEcCtD
Betahistine—Dermatitis—Vinorelbine—breast cancer	0.000718	0.000845	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—breast cancer	0.000718	0.000844	CcSEcCtD
Betahistine—Ill-defined disorder—Capecitabine—breast cancer	0.000715	0.000841	CcSEcCtD
Betahistine—Urticaria—Fluorouracil—breast cancer	0.000715	0.000841	CcSEcCtD
Betahistine—Headache—Vinorelbine—breast cancer	0.000714	0.00084	CcSEcCtD
Betahistine—Asthma—Doxorubicin—breast cancer	0.000713	0.000839	CcSEcCtD
Betahistine—Malaise—Capecitabine—breast cancer	0.000695	0.000818	CcSEcCtD
Betahistine—Hypersensitivity—Mitoxantrone—breast cancer	0.000692	0.000815	CcSEcCtD
Betahistine—Hypersensitivity—Irinotecan—breast cancer	0.000692	0.000815	CcSEcCtD
Betahistine—Vomiting—Thiotepa—breast cancer	0.000692	0.000814	CcSEcCtD
Betahistine—Convulsion—Docetaxel—breast cancer	0.00069	0.000811	CcSEcCtD
Betahistine—Rash—Thiotepa—breast cancer	0.000686	0.000807	CcSEcCtD
Betahistine—Dermatitis—Thiotepa—breast cancer	0.000686	0.000807	CcSEcCtD
Betahistine—Dyspnoea—Paclitaxel—breast cancer	0.000683	0.000804	CcSEcCtD
Betahistine—Headache—Thiotepa—breast cancer	0.000682	0.000802	CcSEcCtD
Betahistine—Somnolence—Paclitaxel—breast cancer	0.000681	0.000802	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000681	0.000801	CcSEcCtD
Betahistine—Nausea—Vinorelbine—breast cancer	0.000677	0.000796	CcSEcCtD
Betahistine—Dyspepsia—Paclitaxel—breast cancer	0.000675	0.000794	CcSEcCtD
Betahistine—Asthenia—Mitoxantrone—breast cancer	0.000674	0.000793	CcSEcCtD
Betahistine—Asthenia—Irinotecan—breast cancer	0.000674	0.000793	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000673	0.000792	CcSEcCtD
Betahistine—Hypersensitivity—Fluorouracil—breast cancer	0.000663	0.00078	CcSEcCtD
Betahistine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000662	0.000779	CcSEcCtD
Betahistine—Fatigue—Paclitaxel—breast cancer	0.000661	0.000777	CcSEcCtD
Betahistine—Asthenia—Gemcitabine—breast cancer	0.000657	0.000773	CcSEcCtD
Betahistine—Confusional state—Docetaxel—breast cancer	0.000655	0.000771	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000652	0.000767	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—breast cancer	0.00065	0.000764	CcSEcCtD
Betahistine—Discomfort—Capecitabine—breast cancer	0.000648	0.000763	CcSEcCtD
Betahistine—Pruritus—Gemcitabine—breast cancer	0.000648	0.000762	CcSEcCtD
Betahistine—Nausea—Thiotepa—breast cancer	0.000646	0.000761	CcSEcCtD
Betahistine—Diarrhoea—Mitoxantrone—breast cancer	0.000643	0.000757	CcSEcCtD
Betahistine—Diarrhoea—Irinotecan—breast cancer	0.000643	0.000757	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—breast cancer	0.000637	0.00075	CcSEcCtD
Betahistine—Pruritus—Fluorouracil—breast cancer	0.000637	0.000749	CcSEcCtD
Betahistine—Confusional state—Capecitabine—breast cancer	0.000634	0.000746	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—breast cancer	0.000634	0.000746	CcSEcCtD
Betahistine—Feeling abnormal—Paclitaxel—breast cancer	0.000632	0.000743	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—breast cancer	0.000631	0.000742	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.00063	0.000742	CcSEcCtD
Betahistine—Diarrhoea—Gemcitabine—breast cancer	0.000626	0.000737	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—breast cancer	0.000623	0.000733	CcSEcCtD
Betahistine—Dizziness—Irinotecan—breast cancer	0.000621	0.000731	CcSEcCtD
Betahistine—Nervous system disorder—Capecitabine—breast cancer	0.000617	0.000726	CcSEcCtD
Betahistine—Diarrhoea—Fluorouracil—breast cancer	0.000616	0.000725	CcSEcCtD
Betahistine—Tachycardia—Capecitabine—breast cancer	0.000614	0.000722	CcSEcCtD
Betahistine—Skin disorder—Capecitabine—breast cancer	0.000611	0.000719	CcSEcCtD
Betahistine—Urticaria—Paclitaxel—breast cancer	0.000609	0.000716	CcSEcCtD
Betahistine—Vomiting—Mitoxantrone—breast cancer	0.000598	0.000703	CcSEcCtD
Betahistine—Vomiting—Irinotecan—breast cancer	0.000598	0.000703	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—breast cancer	0.000595	0.0007	CcSEcCtD
Betahistine—Dizziness—Fluorouracil—breast cancer	0.000595	0.0007	CcSEcCtD
Betahistine—Rash—Mitoxantrone—breast cancer	0.000593	0.000697	CcSEcCtD
Betahistine—Rash—Irinotecan—breast cancer	0.000593	0.000697	CcSEcCtD
Betahistine—Dermatitis—Mitoxantrone—breast cancer	0.000592	0.000697	CcSEcCtD
Betahistine—Dermatitis—Irinotecan—breast cancer	0.000592	0.000697	CcSEcCtD
Betahistine—Headache—Mitoxantrone—breast cancer	0.000589	0.000693	CcSEcCtD
Betahistine—Headache—Irinotecan—breast cancer	0.000589	0.000693	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—breast cancer	0.000583	0.000686	CcSEcCtD
Betahistine—Vomiting—Gemcitabine—breast cancer	0.000582	0.000685	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—breast cancer	0.000579	0.000681	CcSEcCtD
Betahistine—Somnolence—Docetaxel—breast cancer	0.000578	0.000679	CcSEcCtD
Betahistine—Rash—Gemcitabine—breast cancer	0.000577	0.000679	CcSEcCtD
Betahistine—Dermatitis—Gemcitabine—breast cancer	0.000577	0.000678	CcSEcCtD
Betahistine—Headache—Gemcitabine—breast cancer	0.000574	0.000675	CcSEcCtD
Betahistine—Vomiting—Fluorouracil—breast cancer	0.000572	0.000673	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—breast cancer	0.000572	0.000673	CcSEcCtD
Betahistine—Rash—Fluorouracil—breast cancer	0.000568	0.000668	CcSEcCtD
Betahistine—Dermatitis—Fluorouracil—breast cancer	0.000567	0.000667	CcSEcCtD
Betahistine—Hypersensitivity—Paclitaxel—breast cancer	0.000565	0.000664	CcSEcCtD
Betahistine—Headache—Fluorouracil—breast cancer	0.000564	0.000663	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000561	0.00066	CcSEcCtD
Betahistine—Dyspnoea—Capecitabine—breast cancer	0.000561	0.00066	CcSEcCtD
Betahistine—Fatigue—Docetaxel—breast cancer	0.00056	0.000659	CcSEcCtD
Betahistine—Nausea—Mitoxantrone—breast cancer	0.000558	0.000657	CcSEcCtD
Betahistine—Nausea—Irinotecan—breast cancer	0.000558	0.000657	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—breast cancer	0.000557	0.000655	CcSEcCtD
Betahistine—Dyspepsia—Capecitabine—breast cancer	0.000554	0.000651	CcSEcCtD
Betahistine—Asthenia—Paclitaxel—breast cancer	0.00055	0.000647	CcSEcCtD
Betahistine—Nausea—Gemcitabine—breast cancer	0.000544	0.00064	CcSEcCtD
Betahistine—Gastrointestinal disorder—Capecitabine—breast cancer	0.000543	0.000639	CcSEcCtD
Betahistine—Fatigue—Capecitabine—breast cancer	0.000542	0.000638	CcSEcCtD
Betahistine—Pruritus—Paclitaxel—breast cancer	0.000542	0.000638	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—breast cancer	0.00054	0.000635	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—breast cancer	0.000535	0.00063	CcSEcCtD
Betahistine—Nausea—Fluorouracil—breast cancer	0.000535	0.000629	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—breast cancer	0.000532	0.000626	CcSEcCtD
Betahistine—Flatulence—Epirubicin—breast cancer	0.000529	0.000622	CcSEcCtD
Betahistine—Diarrhoea—Paclitaxel—breast cancer	0.000524	0.000617	CcSEcCtD
Betahistine—Feeling abnormal—Capecitabine—breast cancer	0.000518	0.00061	CcSEcCtD
Betahistine—Malaise—Methotrexate—breast cancer	0.000517	0.000609	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—breast cancer	0.000515	0.000606	CcSEcCtD
Betahistine—Dizziness—Paclitaxel—breast cancer	0.000507	0.000596	CcSEcCtD
Betahistine—Urticaria—Capecitabine—breast cancer	0.0005	0.000588	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—breast cancer	0.000498	0.000586	CcSEcCtD
Betahistine—Convulsion—Methotrexate—breast cancer	0.000497	0.000585	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—breast cancer	0.00049	0.000576	CcSEcCtD
Betahistine—Vomiting—Paclitaxel—breast cancer	0.000487	0.000573	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000485	0.000571	CcSEcCtD
Betahistine—Malaise—Epirubicin—breast cancer	0.000484	0.00057	CcSEcCtD
Betahistine—Rash—Paclitaxel—breast cancer	0.000483	0.000569	CcSEcCtD
Betahistine—Dermatitis—Paclitaxel—breast cancer	0.000483	0.000568	CcSEcCtD
Betahistine—Discomfort—Methotrexate—breast cancer	0.000483	0.000568	CcSEcCtD
Betahistine—Headache—Paclitaxel—breast cancer	0.00048	0.000565	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—breast cancer	0.000479	0.000563	CcSEcCtD
Betahistine—Confusional state—Methotrexate—breast cancer	0.000472	0.000555	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—breast cancer	0.000468	0.000551	CcSEcCtD
Betahistine—Asthenia—Docetaxel—breast cancer	0.000466	0.000548	CcSEcCtD
Betahistine—Convulsion—Epirubicin—breast cancer	0.000465	0.000547	CcSEcCtD
Betahistine—Hypersensitivity—Capecitabine—breast cancer	0.000463	0.000545	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—breast cancer	0.000461	0.000542	CcSEcCtD
Betahistine—Pruritus—Docetaxel—breast cancer	0.00046	0.000541	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—breast cancer	0.000459	0.00054	CcSEcCtD
Betahistine—Nausea—Paclitaxel—breast cancer	0.000455	0.000536	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—breast cancer	0.000455	0.000535	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000454	0.000534	CcSEcCtD
Betahistine—Discomfort—Epirubicin—breast cancer	0.000452	0.000531	CcSEcCtD
Betahistine—Asthenia—Capecitabine—breast cancer	0.000451	0.000531	CcSEcCtD
Betahistine—Malaise—Doxorubicin—breast cancer	0.000448	0.000527	CcSEcCtD
Betahistine—Pruritus—Capecitabine—breast cancer	0.000445	0.000524	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—breast cancer	0.000445	0.000523	CcSEcCtD
Betahistine—Confusional state—Epirubicin—breast cancer	0.000442	0.00052	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—breast cancer	0.000438	0.000516	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—breast cancer	0.00043	0.000506	CcSEcCtD
Betahistine—Diarrhoea—Capecitabine—breast cancer	0.00043	0.000506	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—breast cancer	0.00043	0.000506	CcSEcCtD
Betahistine—Dizziness—Docetaxel—breast cancer	0.00043	0.000505	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—breast cancer	0.000428	0.000503	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—breast cancer	0.000426	0.000501	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00042	0.000494	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—breast cancer	0.000418	0.000492	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—breast cancer	0.000417	0.000491	CcSEcCtD
Betahistine—Somnolence—Methotrexate—breast cancer	0.000416	0.00049	CcSEcCtD
Betahistine—Dizziness—Capecitabine—breast cancer	0.000416	0.000489	CcSEcCtD
Betahistine—Vomiting—Docetaxel—breast cancer	0.000413	0.000486	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—breast cancer	0.000412	0.000485	CcSEcCtD
Betahistine—Rash—Docetaxel—breast cancer	0.00041	0.000482	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—breast cancer	0.000409	0.000481	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—breast cancer	0.000409	0.000481	CcSEcCtD
Betahistine—Headache—Docetaxel—breast cancer	0.000407	0.000479	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—breast cancer	0.000405	0.000477	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—breast cancer	0.000404	0.000476	CcSEcCtD
Betahistine—Fatigue—Methotrexate—breast cancer	0.000404	0.000475	CcSEcCtD
Betahistine—Vomiting—Capecitabine—breast cancer	0.0004	0.000471	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—breast cancer	0.000398	0.000468	CcSEcCtD
Betahistine—Rash—Capecitabine—breast cancer	0.000397	0.000467	CcSEcCtD
Betahistine—Dermatitis—Capecitabine—breast cancer	0.000396	0.000466	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—breast cancer	0.000396	0.000466	CcSEcCtD
Betahistine—Headache—Capecitabine—breast cancer	0.000394	0.000464	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—breast cancer	0.000394	0.000463	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—breast cancer	0.000391	0.00046	CcSEcCtD
Betahistine—Somnolence—Epirubicin—breast cancer	0.00039	0.000458	CcSEcCtD
Betahistine—Nausea—Docetaxel—breast cancer	0.000386	0.000454	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—breast cancer	0.000386	0.000454	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—breast cancer	0.000386	0.000454	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—breast cancer	0.000378	0.000445	CcSEcCtD
Betahistine—Fatigue—Epirubicin—breast cancer	0.000378	0.000444	CcSEcCtD
Betahistine—Nausea—Capecitabine—breast cancer	0.000374	0.00044	CcSEcCtD
Betahistine—Urticaria—Methotrexate—breast cancer	0.000372	0.000438	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—breast cancer	0.000361	0.000425	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—breast cancer	0.000361	0.000425	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—breast cancer	0.00036	0.000424	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—breast cancer	0.000357	0.00042	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—breast cancer	0.00035	0.000412	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—breast cancer	0.00035	0.000411	CcSEcCtD
Betahistine—Urticaria—Epirubicin—breast cancer	0.000348	0.00041	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—breast cancer	0.000345	0.000406	CcSEcCtD
Betahistine—Asthenia—Methotrexate—breast cancer	0.000336	0.000395	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—breast cancer	0.000334	0.000393	CcSEcCtD
Betahistine—Pruritus—Methotrexate—breast cancer	0.000331	0.00039	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—breast cancer	0.000323	0.00038	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—breast cancer	0.000322	0.000379	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—breast cancer	0.00032	0.000377	CcSEcCtD
Betahistine—Asthenia—Epirubicin—breast cancer	0.000314	0.00037	CcSEcCtD
Betahistine—Pruritus—Epirubicin—breast cancer	0.00031	0.000365	CcSEcCtD
Betahistine—Dizziness—Methotrexate—breast cancer	0.00031	0.000364	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—breast cancer	0.0003	0.000353	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—breast cancer	0.000299	0.000351	CcSEcCtD
Betahistine—Vomiting—Methotrexate—breast cancer	0.000298	0.00035	CcSEcCtD
Betahistine—Rash—Methotrexate—breast cancer	0.000295	0.000347	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—breast cancer	0.000295	0.000347	CcSEcCtD
Betahistine—Headache—Methotrexate—breast cancer	0.000293	0.000345	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—breast cancer	0.000291	0.000342	CcSEcCtD
Betahistine—Dizziness—Epirubicin—breast cancer	0.00029	0.000341	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—breast cancer	0.000287	0.000337	CcSEcCtD
Betahistine—Vomiting—Epirubicin—breast cancer	0.000279	0.000328	CcSEcCtD
Betahistine—Nausea—Methotrexate—breast cancer	0.000278	0.000327	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—breast cancer	0.000277	0.000326	CcSEcCtD
Betahistine—Rash—Epirubicin—breast cancer	0.000276	0.000325	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—breast cancer	0.000276	0.000325	CcSEcCtD
Betahistine—Headache—Epirubicin—breast cancer	0.000275	0.000323	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—breast cancer	0.000268	0.000315	CcSEcCtD
Betahistine—Nausea—Epirubicin—breast cancer	0.00026	0.000306	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—breast cancer	0.000258	0.000303	CcSEcCtD
Betahistine—Rash—Doxorubicin—breast cancer	0.000256	0.000301	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—breast cancer	0.000255	0.0003	CcSEcCtD
Betahistine—Headache—Doxorubicin—breast cancer	0.000254	0.000299	CcSEcCtD
Betahistine—Nausea—Doxorubicin—breast cancer	0.000241	0.000283	CcSEcCtD
Betahistine—HRH1—GPCR downstream signaling—CXCL2—breast cancer	0.000114	0.000761	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WWOX—breast cancer	0.000113	0.000756	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WNT10B—breast cancer	0.000113	0.000756	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—WNT1—breast cancer	0.000113	0.000755	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTHLH—breast cancer	0.000113	0.000752	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SPP1—breast cancer	0.000111	0.00074	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL8—breast cancer	0.000111	0.000737	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDE2A—breast cancer	0.00011	0.000737	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL3—breast cancer	0.00011	0.000737	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL27—breast cancer	0.00011	0.000737	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INHBB—breast cancer	0.00011	0.000737	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB3—breast cancer	0.00011	0.000732	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGFR2—breast cancer	0.00011	0.000731	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDNRB—breast cancer	0.000109	0.000729	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2—breast cancer	0.000106	0.000704	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—DLL4—breast cancer	0.000105	0.000703	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BMPR2—breast cancer	0.000105	0.000703	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TERT—breast cancer	0.000105	0.000702	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR2—breast cancer	0.000104	0.000691	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL2—breast cancer	0.000104	0.000691	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTHLH—breast cancer	0.000102	0.000683	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGFR1—breast cancer	0.000102	0.000681	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDH5—breast cancer	0.000101	0.000674	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HIF1A—breast cancer	0.000101	0.000671	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CALCA—breast cancer	9.94e-05	0.000662	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDNRB—breast cancer	9.93e-05	0.000662	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SFRP2—breast cancer	9.91e-05	0.000661	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LEP—breast cancer	9.83e-05	0.000655	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CAV1—breast cancer	9.74e-05	0.000649	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRLR—breast cancer	9.73e-05	0.000649	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL12—breast cancer	9.7e-05	0.000647	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR4—breast cancer	9.7e-05	0.000647	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	9.7e-05	0.000646	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KDR—breast cancer	9.63e-05	0.000642	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VCP—breast cancer	9.4e-05	0.000626	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GLI2—breast cancer	9.4e-05	0.000626	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ESR1—breast cancer	9.38e-05	0.000625	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	9.34e-05	0.000623	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FN1—breast cancer	9.27e-05	0.000618	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEPR—breast cancer	9.24e-05	0.000616	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	9.22e-05	0.000615	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NFKBIA—breast cancer	9.16e-05	0.00061	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH1—breast cancer	9.07e-05	0.000605	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CALCA—breast cancer	9.02e-05	0.000602	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	8.95e-05	0.000597	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APC—breast cancer	8.87e-05	0.000591	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KIT—breast cancer	8.87e-05	0.000591	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CG—breast cancer	8.87e-05	0.000591	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR4—breast cancer	8.81e-05	0.000588	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL12—breast cancer	8.81e-05	0.000588	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR1—breast cancer	8.78e-05	0.000585	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGF—breast cancer	8.77e-05	0.000584	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	8.71e-05	0.000581	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ARHGDIA—breast cancer	8.59e-05	0.000573	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK3—breast cancer	8.49e-05	0.000566	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FST—breast cancer	8.37e-05	0.000558	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—BRAF—breast cancer	8.34e-05	0.000556	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HEY2—breast cancer	8.27e-05	0.000551	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RPS6KB2—breast cancer	8.17e-05	0.000545	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1—breast cancer	8.12e-05	0.000541	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT2—breast cancer	8.11e-05	0.000541	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—breast cancer	8.08e-05	0.000539	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RGS2—breast cancer	8.08e-05	0.000539	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	8.01e-05	0.000534	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL20—breast cancer	7.99e-05	0.000533	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR1—breast cancer	7.97e-05	0.000531	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ITPR1—breast cancer	7.88e-05	0.000525	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CD—breast cancer	7.8e-05	0.00052	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LPAR1—breast cancer	7.74e-05	0.000516	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TLE3—breast cancer	7.74e-05	0.000516	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CA—breast cancer	7.72e-05	0.000515	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SERPINE1—breast cancer	7.71e-05	0.000514	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HEY1—breast cancer	7.66e-05	0.000511	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KRAS—breast cancer	7.63e-05	0.000509	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—DLL1—breast cancer	7.51e-05	0.000501	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	7.41e-05	0.000494	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	7.37e-05	0.000491	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	7.37e-05	0.000491	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOS3—breast cancer	7.36e-05	0.000491	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRB7—breast cancer	7.31e-05	0.000487	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDE4D—breast cancer	7.31e-05	0.000487	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CSF2—breast cancer	7.27e-05	0.000485	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TAB2—breast cancer	7.18e-05	0.000479	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ITPR1—breast cancer	7.15e-05	0.000477	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CNR2—breast cancer	7.12e-05	0.000475	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL8—breast cancer	7.12e-05	0.000474	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MMP3—breast cancer	7.1e-05	0.000474	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	7.09e-05	0.000473	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CA—breast cancer	7.01e-05	0.000467	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MDM2—breast cancer	6.98e-05	0.000466	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RAF1—breast cancer	6.96e-05	0.000464	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—DKK1—breast cancer	6.95e-05	0.000463	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RELA—breast cancer	6.93e-05	0.000462	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFC—breast cancer	6.9e-05	0.00046	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB2—breast cancer	6.89e-05	0.000459	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CB—breast cancer	6.8e-05	0.000453	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MTOR—breast cancer	6.8e-05	0.000453	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAG2—breast cancer	6.79e-05	0.000453	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WNT1—breast cancer	6.69e-05	0.000446	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	6.68e-05	0.000445	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CSF2—breast cancer	6.6e-05	0.00044	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL8—breast cancer	6.53e-05	0.000435	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—HRAS—breast cancer	6.49e-05	0.000433	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1B—breast cancer	6.38e-05	0.000425	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH4—breast cancer	6.35e-05	0.000423	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—breast cancer	6.31e-05	0.000421	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GZMB—breast cancer	6.31e-05	0.00042	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP3—breast cancer	6.25e-05	0.000417	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2—breast cancer	6.24e-05	0.000416	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—breast cancer	6.21e-05	0.000414	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL2—breast cancer	6.12e-05	0.000408	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR2—breast cancer	6.12e-05	0.000408	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCND1—breast cancer	6.08e-05	0.000406	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JUN—breast cancer	6.07e-05	0.000405	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTHLH—breast cancer	6.05e-05	0.000404	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BMP2—breast cancer	6.05e-05	0.000404	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CTNNB1—breast cancer	6.02e-05	0.000402	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—breast cancer	5.91e-05	0.000394	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1A—breast cancer	5.89e-05	0.000392	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTEN—breast cancer	5.87e-05	0.000391	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDNRB—breast cancer	5.86e-05	0.000391	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PGR—breast cancer	5.8e-05	0.000387	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—THBS1—breast cancer	5.78e-05	0.000385	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK8—breast cancer	5.74e-05	0.000383	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—breast cancer	5.73e-05	0.000382	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FLT1—breast cancer	5.51e-05	0.000368	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF3—breast cancer	5.49e-05	0.000366	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SQSTM1—breast cancer	5.49e-05	0.000366	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	5.46e-05	0.000364	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SRC—breast cancer	5.45e-05	0.000363	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAG1—breast cancer	5.42e-05	0.000361	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PARP1—breast cancer	5.4e-05	0.00036	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH3—breast cancer	5.4e-05	0.00036	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CALCA—breast cancer	5.33e-05	0.000355	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—breast cancer	5.3e-05	0.000354	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RPS6—breast cancer	5.27e-05	0.000351	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—breast cancer	5.25e-05	0.00035	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF4—breast cancer	5.23e-05	0.000348	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL12—breast cancer	5.21e-05	0.000347	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR4—breast cancer	5.21e-05	0.000347	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PAK1—breast cancer	5.11e-05	0.000341	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TCF7L2—breast cancer	5.02e-05	0.000335	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK3—breast cancer	5.02e-05	0.000334	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT2—breast cancer	5e-05	0.000333	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	4.96e-05	0.000331	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—breast cancer	4.88e-05	0.000325	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—breast cancer	4.87e-05	0.000325	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH2—breast cancer	4.84e-05	0.000323	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	4.84e-05	0.000323	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	4.8e-05	0.00032	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—breast cancer	4.77e-05	0.000318	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRL—breast cancer	4.71e-05	0.000314	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR1—breast cancer	4.71e-05	0.000314	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STK11—breast cancer	4.64e-05	0.000309	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADAM10—breast cancer	4.64e-05	0.000309	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLG—breast cancer	4.59e-05	0.000306	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT2—breast cancer	4.54e-05	0.000303	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF10—breast cancer	4.51e-05	0.000301	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KRAS—breast cancer	4.51e-05	0.000301	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	4.36e-05	0.000291	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFA—breast cancer	4.36e-05	0.00029	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFBR2—breast cancer	4.29e-05	0.000286	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ITPR1—breast cancer	4.22e-05	0.000282	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB4—breast cancer	4.2e-05	0.00028	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT5A—breast cancer	4.2e-05	0.00028	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP3—breast cancer	4.2e-05	0.00028	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	4.18e-05	0.000279	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CA—breast cancer	4.14e-05	0.000276	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SMAD4—breast cancer	4.06e-05	0.000271	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1R—breast cancer	4.04e-05	0.000269	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	4.02e-05	0.000268	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TP53—breast cancer	4.01e-05	0.000267	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HES1—breast cancer	3.97e-05	0.000265	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NCOR1—breast cancer	3.95e-05	0.000263	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	3.95e-05	0.000263	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CSF2—breast cancer	3.9e-05	0.00026	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF1—breast cancer	3.9e-05	0.00026	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RAF1—breast cancer	3.89e-05	0.000259	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRG1—breast cancer	3.87e-05	0.000258	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—H2AFX—breast cancer	3.84e-05	0.000256	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2—breast cancer	3.84e-05	0.000256	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRAS—breast cancer	3.83e-05	0.000256	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—E2F1—breast cancer	3.82e-05	0.000255	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	3.8e-05	0.000253	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—breast cancer	3.67e-05	0.000245	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SPP1—breast cancer	3.67e-05	0.000245	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL8—breast cancer	3.65e-05	0.000243	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB3—breast cancer	3.63e-05	0.000242	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGFR2—breast cancer	3.62e-05	0.000241	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2—breast cancer	3.49e-05	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TERT—breast cancer	3.48e-05	0.000232	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—breast cancer	3.38e-05	0.000226	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGFR1—breast cancer	3.38e-05	0.000225	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIF1A—breast cancer	3.33e-05	0.000222	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEP—breast cancer	3.25e-05	0.000216	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CAV1—breast cancer	3.22e-05	0.000214	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KDR—breast cancer	3.18e-05	0.000212	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ESR1—breast cancer	3.1e-05	0.000207	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FN1—breast cancer	3.06e-05	0.000204	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NFKBIA—breast cancer	3.03e-05	0.000202	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH1—breast cancer	3e-05	0.0002	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APC—breast cancer	2.93e-05	0.000195	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CG—breast cancer	2.93e-05	0.000195	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KIT—breast cancer	2.93e-05	0.000195	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGF—breast cancer	2.9e-05	0.000193	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK3—breast cancer	2.81e-05	0.000187	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BRAF—breast cancer	2.75e-05	0.000184	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1—breast cancer	2.68e-05	0.000179	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT2—breast cancer	2.68e-05	0.000179	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—breast cancer	2.67e-05	0.000178	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CD—breast cancer	2.58e-05	0.000172	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	2.55e-05	0.00017	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SERPINE1—breast cancer	2.55e-05	0.00017	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KRAS—breast cancer	2.52e-05	0.000168	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOS3—breast cancer	2.43e-05	0.000162	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	2.32e-05	0.000154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MDM2—breast cancer	2.31e-05	0.000154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RAF1—breast cancer	2.3e-05	0.000153	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RELA—breast cancer	2.29e-05	0.000153	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB2—breast cancer	2.27e-05	0.000152	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MTOR—breast cancer	2.24e-05	0.00015	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CB—breast cancer	2.24e-05	0.00015	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL8—breast cancer	2.16e-05	0.000144	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HRAS—breast cancer	2.14e-05	0.000143	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.11e-05	0.00014	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.08e-05	0.000139	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP3—breast cancer	2.06e-05	0.000138	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2—breast cancer	2.06e-05	0.000137	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—breast cancer	2.05e-05	0.000137	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCND1—breast cancer	2.01e-05	0.000134	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JUN—breast cancer	2.01e-05	0.000134	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.99e-05	0.000133	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—breast cancer	1.95e-05	0.00013	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.94e-05	0.00013	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTEN—breast cancer	1.94e-05	0.000129	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.9e-05	0.000127	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.89e-05	0.000126	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SRC—breast cancer	1.8e-05	0.00012	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.75e-05	0.000117	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—breast cancer	1.73e-05	0.000116	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.66e-05	0.00011	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—breast cancer	1.61e-05	0.000107	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.61e-05	0.000107	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—breast cancer	1.58e-05	0.000105	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KRAS—breast cancer	1.49e-05	9.93e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.37e-05	9.12e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TP53—breast cancer	1.32e-05	8.83e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HRAS—breast cancer	1.27e-05	8.44e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—breast cancer	1.21e-05	8.08e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—breast cancer	1.12e-05	7.45e-05	CbGpPWpGaD
